Advanced/Metastatic Solid Tumors

Also known as: Advanced / Metastatic Solid Tumor / Advanced/Metastatic Solid Tumor / Advanced and Metastatic Solid Tumor / Metastatic and Advanced Solid Tumors / Advanced and/or Metastatic Solid Tumors / Advanced or Metastatic Solid Tumor / Advanced or Metastatic Solid Tumors / Advanced / Metastatic Solid Tumors / Advanced/ Metastatic Solid Tumors

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB16423	AK119	1	Active Not Recruiting	1
DB15568	Adagrasib	1	Active Not Recruiting	1
DB00062	Albumin human	1	Active Not Recruiting	1
DB06626	Axitinib	1	Active Not Recruiting	1
DB00112	Bevacizumab	1	Completed	1
DB00112	Bevacizumab	1	Recruiting	1
DB00188	Bortezomib	1	Completed	1
DB16741	Bortezomib D-mannitol	1	Completed	1
DB16680	Cadonilimab	1	Active Not Recruiting	1
DB01101	Capecitabine	1	Completed	1
DB00958	Carboplatin	1	Active Not Recruiting	1
DB00958	Carboplatin	1	Withdrawn	1
DB00002	Cetuximab	1	Active Not Recruiting	1
DB00515	Cisplatin	1	Active Not Recruiting	1
DB00515	Cisplatin	1	Withdrawn	1
DB12483	Copanlisib	1	Completed	1
DB15769	Envafolimab	1	Completed	1
DB15149	Futibatinib	1	Recruiting	1
DB00441	Gemcitabine	1	Withdrawn	1
DB06080	Linifanib	1	Terminated	1
DB12498	Mogamulizumab	1	Terminated	1
DB09035	Nivolumab	1	Active Not Recruiting	1
DB09035	Nivolumab	1	Completed	1
DB15110	Onvansertib	1	Completed	1
DB12686	PHA-793887	1	Terminated	1
DB01229	Paclitaxel	1	Active Not Recruiting	1
DB01229	Paclitaxel	1	Withdrawn	1
DB09037	Pembrolizumab	1	Active Not Recruiting	2
DB09037	Pembrolizumab	1	Completed	3
DB09037	Pembrolizumab	1	Not Yet Recruiting	1
DB09037	Pembrolizumab	1	Recruiting	5
DB00642	Pemetrexed	1	Active Not Recruiting	1
DB00642	Pemetrexed	1	Withdrawn	1
DB05578	Ramucirumab	1	Recruiting	1
DB15766	Retifanlimab	1	Withdrawn	1
DB15078	Rogaratinib	1	Completed	1
DB05210	SF1126	1	Completed	1
DB12893	Sacituzumab govitecan	1	Recruiting	1
DB14958	Selicrelumab	1	Completed	1
DB11689	Selumetinib	1	Completed	1
DB17451	Serplulimab	1	Active Not Recruiting	1
DB15765	Sintilimab	1	Terminated	1
DB14892	Spartalizumab	1	Terminated	1
DB15106	Surufatinib	1	Terminated	1
DB08937	TAS-102	1	Completed	1
DB08937	TAS-102	1	Recruiting	1
DB14876	TAS-116	1	Recruiting	1
DB09343	Tipiracil	1	Completed	1
DB08911	Trametinib	1	Recruiting	1
DB00432	Trifluridine	1	Completed	1
DB03754	Tromethamine	1	Completed	1
DB15113	Utomilumab	1	Terminated	1
DB12317	Vanucizumab	1	Completed	1
DB12723	Varlitinib	1	Completed	1
DB17505	Zimberelimab	1	Recruiting	1
DB00062	Albumin human	1 / 2	Recruiting	1
DB00928	Azacitidine	1 / 2	Completed	1
DB01101	Capecitabine	1 / 2	Terminated	1
DB00958	Carboplatin	1 / 2	Withdrawn	1
DB18216	Cavrotolimod	1 / 2	Terminated	1
DB14707	Cemiplimab	1 / 2	Terminated	1
DB00515	Cisplatin	1 / 2	Terminated	1
DB05239	Cobimetinib	1 / 2	Active Not Recruiting	1
DB00531	Cyclophosphamide	1 / 2	Recruiting	1
DB01248	Docetaxel	1 / 2	Withdrawn	1
DB17446	Erfonrilimab	1 / 2	Not Yet Recruiting	1
DB01073	Fludarabine	1 / 2	Recruiting	1
DB11977	Golvatinib	1 / 2	Terminated	1
DB06186	Ipilimumab	1 / 2	Active Not Recruiting	1
DB15191	MAX-40279	1 / 2	Not Yet Recruiting	1
DB06132	Nivolumab	1 / 2	Active Not Recruiting	1
DB09035	Nivolumab	1 / 2	Active Not Recruiting	1
DB09035	Nivolumab	1 / 2	Completed	1
DB01229	Paclitaxel	1 / 2	Completed	1
DB01229	Paclitaxel	1 / 2	Recruiting	1
DB01229	Paclitaxel	1 / 2	Withdrawn	1
DB09037	Pembrolizumab	1 / 2	Active Not Recruiting	1
DB09037	Pembrolizumab	1 / 2	Recruiting	3
DB09037	Pembrolizumab	1 / 2	Terminated	1
DB00642	Pemetrexed	1 / 2	Withdrawn	1
DB15015	Recombinant CD40-ligand	1 / 2	Recruiting	1
DB08896	Regorafenib	1 / 2	Completed	1
DB16406	Subasumstat	1 / 2	Active Not Recruiting	1
DB15149	Futibatinib	2	Active Not Recruiting	1
DB15102	Pemigatinib	2	Terminated	1